Skip to content
healthcare.dev

Kesin MAG-AL Plus

NDC 81033-006, Aluminum and Magnesium Hydroxide w/Simethicone Suspension, suspension, from Kesin Pharma Corporation.

Product NDC
81033-006
Status
Listed
Labeler
Kesin Pharma Corporation
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M001
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81033-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALUMINUM HYDROXIDE200 mg/5mL
  • MAGNESIUM HYDROXIDE200 mg/5mL
  • DIMETHICONE, UNSPECIFIED20 mg/5mL

Pharmacologic classes

Calculi Dissolution Agent [EPC]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Skin Barrier Activity [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
81033-006-0181033000601100 CUP, UNIT-DOSE in 1 CASE (81033-006-01) / 30 mL in 1 CUP, UNIT-DOSE (81033-006-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 81033-006 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81033-006 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81033-006. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.